Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Neurology
•
Neuromuscular
Does the levels of GM1 antibody (IGG or IGM- tested by the enzyme immunoassay (EIA) method) reduce after treatment for CIDP with IVIG?
should this be monitored over time ?
Related Questions
When do you consider spinal cord stimulator for patients with neuropathic pain?
At what point do you consider weaning steroids or immuno-modulating agents in patients with Myasthenia Gravis?
How frequently do you check CK in patients with Becker's muscular dystrophy?
What is your approach to the management of Bell's palsy that has not improved after six months?
In what clinical situation do you recommend a pudendal EMG/NCS?
How do you counsel patients with postmedian sternotomy plexopathy?
What workup do you initiate for thoracic outlet syndrome?
How do you initiate steroids in ocular Myasthenia Gravis?
Would you avoid combining JAK inhibitors with IVIG given the risk of thromboembolism?
Is history of GBS a contraindication for all future flu vaccines?